Allergic Conjunctivitis

134 clinical trials · Condition

Record	Firm	Date
Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis (NCT00331500)	Alcon Research	2006-04-18
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis (NCT00244543)	Vistakon Pharmaceuticals	2005-10-01
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis (NCT00241319)	Vistakon Pharmaceuticals	2005-10-01
Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan (NCT00276445)	Meiji University of Oriental Medicine	2004-01-01
Effect of Olopatadine on Allergic Tear Mediators (NCT00609128)	University of Wisconsin, Madison	2000-09-01
Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 (NCT00298337)	University of Helsinki	1999-10-01
Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis (NCT01363700)	Santen Pharmaceutical Co., Ltd.
Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study (NCT00443105)	Assaf-Harofeh Medical Center
A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis (NCT01363713)	Santen Pharmaceutical Co., Ltd.
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis (NCT00375596)	Bausch & Lomb Incorporated

Every clearance here is in the API, with alerts when new ones post.